Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-04

Clinical Trial Update: Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy [NA]

View source ↗

Summary

A clinical trial update describes a planned study to evaluate mavacamten in combination with radiofrequency ablation for symptomatic obstructive hypertrophic ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Obstructive Hypertrophic Cardiomyopathy, Mavacamten | NA | Status: NOT_YET_RECRUITING